Mindray Medical International (NYSE:MR) was upgraded from Neutral to Buy at Goldman Sachs today. The stock closed yesterday at $33.72 on volume of 259,000 shares, below average daily volume of 559,000.

There is potential upside of 10.7% for shares of Mindray Medical International based on a current price of $33.72 and an average consensus analyst price target of $37.33. The stock should find initial support at its 50-day moving average (MA) of $33.40 and further support at its 200-day MA of $32.71.

Mindray Medical International Limited develops, manufactures, and markets medical devices. The Company offers patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems.

In the past 52 weeks, Mindray Medical International share prices have been bracketed by a low of $26.17 and a high of $36.36 and closed yesterday at $33.72, 29% above that low price. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.

SmarTrend is tracking the current trend status for Mindray Medical International and will alert subscribers who have MR in their portfolio or watchlist when shares have changed trend direction.